Himisha Beltran, MD of Dana Farber @DanaFarber discusses circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer and patients as they progress on treatment.
Read here; https://www.jci.org/articles/view/131041
Advertisement